tiprankstipranks
Trending News
More News >

Nephros Holds Annual Stockholders Meeting June 2025

Story Highlights
Nephros Holds Annual Stockholders Meeting June 2025

Don’t Miss TipRanks’ Half-Year Sale

Nephros ( (NEPH) ) just unveiled an announcement.

On June 16, 2025, Nephros, Inc. conducted its Annual Meeting of Stockholders where several key decisions were made. Stockholders elected Lisa Nettis to the Board of Directors for a term ending in 2028, ratified Baker Tilly US, LLP as the independent public accounting firm for 2025, and approved the executive officers’ compensation on a non-binding basis. These decisions reflect the company’s ongoing governance and operational strategies.

The most recent analyst rating on (NEPH) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Nephros stock, see the NEPH Stock Forecast page.

Spark’s Take on NEPH Stock

According to Spark, TipRanks’ AI Analyst, NEPH is a Neutral.

Nephros is showing signs of financial stability with a robust balance sheet and improving profitability, which are crucial strengths. However, the high P/E ratio suggests overvaluation, and the recent negative cash flow presents risks. The technical analysis indicates strong momentum, but overbought signals could lead to a short-term price correction.

To see Spark’s full report on NEPH stock, click here.

More about Nephros

Nephros, Inc. operates in the medical device industry, focusing on products related to water filtration and purification, particularly for medical and commercial markets.

Average Trading Volume: 21,227

Technical Sentiment Signal: Buy

Current Market Cap: $41.02M

For a thorough assessment of NEPH stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1